[Ultra-high dose streptokinase in treatment of arterial occlusions of leg arteries in advanced age].

VASA. Supplementum Pub Date : 1993-01-01
C Ploenes, G Broers, M Martin
{"title":"[Ultra-high dose streptokinase in treatment of arterial occlusions of leg arteries in advanced age].","authors":"C Ploenes,&nbsp;G Broers,&nbsp;M Martin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In a retrospective study, the data of 218 patients (age 65-91) with obstructions of leg-arteries were evaluated, who underwent short-term ultrahigh fibrinolytic treatment. Some of the patients were also treated with percutaneous transluminal angioplasty after fibrinolysis. The overall patency-rate was 69 percent in the younger age group (65-74 years) and 46 percent in the group aged > or = 75. It could be shown, however, that the patency-rate was affected positively by concomitant factors (especially at least two patent calf arteries). These factors were less frequently found in the older age group, resulting in a lower patency-rate. Most likely the underlying reason is not age per se, because it could be shown, that the reason, which led to fibrinolytic treatment changed with age: In the younger age-group, Fontaine-stage II led to treatment in the vast majority of cases (71%). There was a shift to stage III (26%) and IV (27%) in the group > or = 75 years. This progression of artery disease usually leads to a reduced success rate of fibrinolytic treatment, because adverse concomitant factors prevail.</p>","PeriodicalId":76788,"journal":{"name":"VASA. Supplementum","volume":"39 ","pages":"17-22"},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"VASA. Supplementum","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In a retrospective study, the data of 218 patients (age 65-91) with obstructions of leg-arteries were evaluated, who underwent short-term ultrahigh fibrinolytic treatment. Some of the patients were also treated with percutaneous transluminal angioplasty after fibrinolysis. The overall patency-rate was 69 percent in the younger age group (65-74 years) and 46 percent in the group aged > or = 75. It could be shown, however, that the patency-rate was affected positively by concomitant factors (especially at least two patent calf arteries). These factors were less frequently found in the older age group, resulting in a lower patency-rate. Most likely the underlying reason is not age per se, because it could be shown, that the reason, which led to fibrinolytic treatment changed with age: In the younger age-group, Fontaine-stage II led to treatment in the vast majority of cases (71%). There was a shift to stage III (26%) and IV (27%) in the group > or = 75 years. This progression of artery disease usually leads to a reduced success rate of fibrinolytic treatment, because adverse concomitant factors prevail.

【超高剂量链激酶治疗老年下肢动脉闭塞】。
在一项回顾性研究中,对218例(65-91岁)腿部动脉阻塞患者的数据进行了评估,这些患者接受了短期超高纤溶治疗。部分患者在纤维蛋白溶解后还行经皮腔内血管成形术。年龄较小的年龄组(65-74岁)的总通畅率为69%,年龄>或= 75岁组的总通畅率为46%。然而,可以证明,伴随因素(尤其是至少两条小腿动脉未闭)对通畅率有积极影响。这些因素在老年组中较少发现,导致较低的通畅率。最可能的根本原因不是年龄本身,因为可以证明,导致纤溶治疗的原因随年龄而变化:在较年轻的年龄组中,绝大多数病例(71%)为fontaine II期。在年龄≥75岁的组中,有III期(26%)和IV期(27%)的转移。动脉疾病的这种进展通常导致纤溶治疗的成功率降低,因为不利的伴随因素普遍存在。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信